Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03848845 |
| Title | Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 4) |
| Acronym | DREAMM 4 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ESP | DEU | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Atlanta | Georgia | 30322 | United States | Details | |
| GSK Investigational Site | Indianapolis | Indiana | 46202 | United States | Details | |
| GSK Investigational Site | Charlotte | North Carolina | 28204 | United States | Details | |
| GSK Investigational Site | Madison | Wisconsin | 53792 | United States | Details | |
| GSK Investigational Site | Calgary | Alberta | T2N 2T9 | Canada | Details | |
| GSK Investigational Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| GSK Investigational Site | Hannover | Niedersachsen | 30625 | Germany | Details | |
| GSK Investigational Site | Berlin | 12200 | Germany | Details | ||
| GSK Investigational Site | Hamburg | 20246 | Germany | Details | ||
| GSK Investigational Site | Badalona | 08916 | Spain | Details | ||
| GSK Investigational Site | Pozuelo De Alarcón/Madrid | 28223 | Spain | Details | ||
| GSK Investigational Site | Salamanca | 37007 | Spain | Details |